Menu
Clinical Laboratory Director
Dr. Miriam Bloch is an accomplished physician with over 25 years of experience in pathology, laboratory medicine, laboratory directorship and pharmaceutical product development. She has board certification in Anatomic and Clinical Pathology and Cytopathology.
She has worked with numerous companies, including Epic Sciences, Ignyta, PPD, Immunovative Therapies and Neogenomics.
Dr. Bloch is a graduate of the University of Pennsylvania and did her medical training at the University of Kansas and the Hospital of the University of Pennsylvania.
A pioneer in the science of detecting mis-folded proteins, Amprion advances the diagnosis of brain disorders. Our SYNTap™️ Biomarker Test aids physicians in diagnosing Parkinson’s, Lewy Body Dementia, and Alzheimer’s with Lewy Body variant. We plan to launch more biomarker tests in the future.
To improve patient access to the SYNTap® Biomarker CSF Test, Amprion offers the following billing options:
Please note: Amprion is a Medicare participating provider, however, the SYNTap test does not currently have Medicare coverage determination. Also, Amprion is not yet in network with most insurers.
The SYNTap Biomarker CSF Test has been issued a dedicated CPT® PLA code to be used when billing: 0393U.
For additional information, please visit our billing page.
